Speaker illustration

Doctor Melissa Middeldorp

University of Adelaide, Adelaide (Australia)

Member of:

European Heart Rythm Association

Dr Middeldorp is an allied professional with a specific interest in risk factor management and lifestyle change particularly in patients with AF. Her research has focused on dedicated clinics to address risk factors. Dr Middeldorp also has an interest in gender difference particularly in outcomes and management of patients.

Weight loss and dietary interventions to prevent atrial fibrillation

Event: ESC Congress 2023

Topic: Atrial Fibrillation (AF)

Session: Lifestyle modifications in atrial fibrillation: what to advise your patient

Thumbnail

Fit-Obese and Unfit-obese: Is there a difference between cardiorespiratory fitness? Implications for AF recurrence

Event: EHRA 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Rehabilitation and Sports Cardiology

Thumbnail

Differences in AF ablation outcomes between genders: long-term outcomes

Event: EHRA 2019

Topic: Treatment

Session: Atrial Fibrillation - Treatment

Thumbnail

Does socioeconomic factors influence the outcomes of risk factor management and freedom of patients with atrial fibrillation

Event: EHRA 2018

Topic: Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation - Clinical

Thumbnail

What and how many reactions caused by novel oral anticoagulation use?

Event: EHRA 2018

Topic: Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation

Session: Atrial fibrillation - Clinical

Thumbnail

The influence of gender on 1-year outcomes of patients undergoing primary AF ablation

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation ablation - Outcomes and predictors

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb